Data as of Dec 19
| +2.45 / +1.87%|
The 13 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 127.00, with a high estimate of 173.00 and a low estimate of 82.00. The median estimate represents a -4.91% decrease from the last price of 133.56.
The current consensus among 14 polled investment analysts is to Hold stock in United Therapeutics Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.